ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
Plos Genetics
Ferrando, Lorenzo L; Vingiani, Andrea A; Garuti, Anna A; Vernieri, Claudio C; Belfiore, Antonino A; Agnelli, Luca L; Dagrada, Gianpaolo G; Ivanoiu, Diana D; Bonizzi, Giuseppina G; Munzone, Elisabetta E; Lippolis, Luana L; Dameri, Martina M; Ravera, Francesco F; Colleoni, Marco M; Viale, Giuseppe G; Magnani, Luca L; Ballestrero, Alberto A; Zoppoli, Gabriele G; Pruneri, Giancarlo G
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.
Plos One
Rudd, Meghan L ML; Hansen, Nancy F NF; Zhang, Xiaolu X; Urick, Mary Ellen ME; Zhang, Suiyuan S; Merino, Maria J MJ; , ; Mullikin, James C JC; Brody, Lawrence C LC; Bell, Daphne W DW
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.
Plos One
Rudd, Meghan L ML; Hansen, Nancy F NF; Zhang, Xiaolu X; Urick, Mary Ellen ME; Zhang, Suiyuan S; Merino, Maria J MJ; , ; Mullikin, James C JC; Brody, Lawrence C LC; Bell, Daphne W DW
Comprehensive omic characterization of breast cancer in Mexican-Hispanic women.
Nature Communications
Romero-Cordoba, Sandra L SL; Salido-Guadarrama, Ivan I; Rebollar-Vega, Rosa R; Bautista-Piña, Veronica V; Dominguez-Reyes, Carlos C; Tenorio-Torres, Alberto A; Villegas-Carlos, Felipe F; Fernández-López, Juan C JC; Uribe-Figueroa, Laura L; Alfaro-Ruiz, Luis L; Hidalgo-Miranda, Alfredo A
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Molecular Oncology
Bertucci, François F; Rypens, Charlotte C; Finetti, Pascal P; Guille, Arnaud A; Adélaïde, José J; Monneur, Audrey A; Carbuccia, Nadine N; Garnier, Séverine S; Dirix, Piet P; Gonçalves, Anthony A; Vermeulen, Peter P; Debeb, Bisrat G BG; Wang, Xiaoping X; Dirix, Luc L; Ueno, Naoto T NT; Viens, Patrice P; Cristofanilli, Massimo M; Chaffanet, Max M; Birnbaum, Daniel D; Van Laere, Steven S
Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer.
Oncology Letters
Vatte, Chittibabu C; Al Amri, Ali Mohammed AM; Cyrus, Cyril C; Chathoth, Shahanas S; Alsayyah, Ahmed A; Ahmad, Arafat A; Akhtar, Mohammed Shakil MS; Alrashidi, Nada Fehaid NF; Jayaseeli, Nithya N; Al Wadani, Hamed H; Al Zahrani, Alhussain A; Al Ali, Amein Kadhem AK
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.
Cancer Research
Wang, Grace M GM; Wong, Hong Yuen HY; Konishi, Hiroyuki H; Blair, Brian G BG; Abukhdeir, Abde M AM; Gustin, John P JP; Rosen, D Marc DM; Denmeade, Samuel Ray SR; Rasheed, Zeshaan Z; Matsui, William W; Garay, Joseph P JP; Mohseni, Morassa M; Higgins, Michaela J MJ; Cidado, Justin J; Jelovac, Danijela D; Croessmann, Sarah S; Cochran, Rory L RL; Karnan, Sivasundaram S; Konishi, Yuko Y; Ota, Akinobu A; Hosokawa, Yoshitaka Y; Argani, Pedram P; Lauring, Josh J; Park, Ben Ho BH
PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport.
Molecular Endocrinology (Baltimore, Md.)
Li, Jing J; Song, Jun J; Cassidy, Margaret G MG; Rychahou, Piotr P; Starr, Marlene E ME; Liu, Jianyu J; Li, Xin X; Epperly, Garretson G; Weiss, Heidi L HL; Townsend, Courtney M CM; Gao, Tianyan T; Evers, B Mark BM